Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.

This Opportunity

Roche’s Clinical Development organization is structured by therapeutic area and is responsible for developing and executing the late development (Phase II – III) clinical strategies and plans that deliver medically-differentiated therapies that provide meaningful improvement to patients.
The Senior Medical Director leads development of the Clinical Development (CD) strategy and plan and is responsible for ensuring effective and efficient execution for the assigned molecule(s)/indication(s).
Senior Medical Directors are expected to demonstrate mastery of the core Medical Clinical Director role, perform their responsibilities mostly independently, and effectively lead multiple projects.
 

EXPERIENCE AND QUALIFICATIONS:
● Academic/Scientific/Clinical:
o M.D. Required
o Relevant clinical, scientific, or clinical trial/development experience in same/similar therapeutic area required
o Academic/teaching background is a plus
o Extensive experience working with the principles and techniques of data analysis, interpretation, and clinical relevance
o Experience publishing results of a clinical trial in a peer-reviewed journal is required
o Extensive pharma/biotech industry experience OR is a recognized expert in the field with significant clinical research experience
o Extensive experience designing and conducting clinical trials (i.e. multiple trials)
o Experience authoring a global clinical development plan is required
o Advanced understanding of Phase II – III drug development
o Knowledge and understanding of Phase I & IV drug development is preferred
o Comprehensive understanding of product and safety profiles
● Regulatory: Advanced understanding of medical aspects of GCP (Good Clinical Practice), ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use), FDA, EMA, and other relevant guidelines and regulations is required.
● Experience leading a HA interaction and submitting an NDA/BLA/MAA to HAs in the US and/or Europe is preferred.
● 6 or more years pharma/biotech experience OR recognized expert in field OR is the equivalent of an Associate Professor. A minimum of 2 years industry experience is strongly preferred.
● Prior people management experience is preferred
● Up to 30% global travel

Key Skills and Behaviours
● Ethics: Has impeccable ethics. Demonstrates, or proven ability to demonstrate, Roche Values
● Attention to detail: Outstanding attention to detail
● Is regarded as an expert in his/her field, is highly respected by others, can effectively contribute to longer-range drug development, and can lead cross-functional teams to successful results
● Has consistently excelled as a cross-functional project team leader
● Business Acumen: Has in-depth knowledge of the pharma/biotech industry, the multiple functions and roles involved in the drug development process. Leads development of disease strategies and plans
● Organization: Can prioritize multiple tasks and goals on time, on target, and within budget
● Interpersonal skills: Strong interpersonal, verbal communication and influencing skills: can influence without authority and has proven experience building and cultivating relationships with key partners and stakeholders, both internally and externally
● Writing: Outstanding written communication skills
● Presentation skills: Strong business presentation skills: effective at summarizing and presenting the key considerations and decision-points.Confident and competent when interacting with others internally and externally: stays focused and on-point, is able to raise problems or challenges in a productive and mature manner
● Negotiation Skills: Strong negotiation skills: can effectively drive discussions and decisions toward desired end-results
● Decision Making: Proven track record of effective decision-making. Makes good business decisions and exercises sound judgment. Consistently and effectively balances decisions with imperatives for ethics and efficacy. Able to make trade-off decisions and determine priorities and goals
● Financial acumen: Strong financial acumen: proven abilities for effective planning, development and oversight of project budgets and other resources. Capable of understanding complex analyses and planning for product valuations and project budgets
● Mentoring: Aptitude or proven ability to mentor colleagues and foster their successful career development

SPECIFIC DUTIES AND RESPONSIBILITIES:
CDP Strategy and Planning
● Leads or delegates development and implementation of the CD plan for assigned molecule(s)/indication(s)
● Gathers and analyzes data and information necessary to create the CD plan
● Responsible and/or accountable to ensure strategic and operational alignment of the CD plan with the relevant CD strategy, strategic and annual LCPs
● Works with and/or oversees other CST members and relevant sub-teams to develop CD plan components (e.g., analytics/data strategy, KOL development, publications strategy, etc.)
● Works with CST and other relevant teams to develop and provide information and input for budget/resource requirements necessary to implement and execute the CD plan
● Stays abreast of internal and external developments, trends and other dynamics relevant to the work of CD to maintain, at all times, a fully current view and perspective of internal/external influences and/or implications for the assigned therapeutic and disease area(s)
● As appropriate, participates in competitive intelligence and/or other market/industry assessment activities and projects
● Maintains the highest standards and levels of scientific and clinical knowledge in the specific therapeutic and disease area(s) of assignment
● Collaborates with a variety of internal and external partners and stakeholders, such as clinical investigators, clinicians, scientists and key opinion leaders (KOLs), as well as multidisciplinary internal groups, including other groups in PD, research, business development, commercial operations, legal, etc.
● Represents CD for the assigned molecule(s)/indication(s) to other internal Roche groups
● May participate in meetings, reviews, discussions and other interactions regarding early development/Phase I studies to provide clinical science input and guidance. Includes reviewing and providing late stage input into Phase I and II protocols
● Supports internal partners in transitioning new drugs/indications into Medical Affairs (MA) studies, including providing CD input for MA study protocol development.
● Consults to pharma partnering on relevant acquisitions, joint ventures or other strategic partnerships, as these potentially relate to the assigned therapeutic/disease area(s)
● Provides, clinical science input into annual and strategic Lifecycle Plans (LCPs) and the Integrated Development Commercialization Plan (IDCP)
CDP Execution
● Leads or oversees others in design, development, and execution of clinical studies
● Collaborates with others in the development of product safety profiles, clinical sections of investigator brochures, presentations and other materials
● May guide and advise others in the identification and selection of appropriate external investigators and sites
● Leads the development and implementation of communications strategies to support ongoing and concluded studies. Includes investigator meetings and KOL interactions, advisory boards, major medical meetings, congresses and other events, publications and other materials
● Accountable and/or responsible to ensure investigators are appropriately and thoroughly briefed, in a timely manner, on medical/scientific matters relating to each study
● Responsible for development and delivery of key presentations, both internally and externally, to convey the CD perspective and provide updates on strategies, plans and other activities. Includes presenting at advisory boards and other relevant external forums representing Roche
● Acts as CD lead or supervises development of study analytics and data management plans
● Leads or supervises ongoing reviews of medical/safety data
● Collaborates with relevant team members to measure and monitor study progress against objectives and plans, including any variances, and proactively communicate any issues, challenges and potential strategies to resolve such
● Collaborates with relevant team members to ensure timely, completion of interim study reporting
● Collaborates with relevant team members and clinical operations to close-out clinical studies, secure data and complete study reporting
● Responsible and/or accountable to ensure correct medical/scientific data interpretation for interim and final study reporting
● Leads ongoing data generation to address unmet medical needs and identify new or extended CD studies for the assigned program or other programs
● Accountable to ensure that CD plans, objectives, and deliverables are consistently accomplished on-time and on-target
● Acts as a medical monitor for assigned studies or delegates this responsibility appropriately

Cross-Functional Team Leadership
● Participates in and/or leads the relevant Clinical Science Team (CST)
● Leads and/or represents CD in sub-teams (e.g. Study Management Teams) relevant to assigned molecule(s)/indication(s) and is responsible for ensuring cross-functional integration, coordination and alignment to enable effective and efficient CD plan execution
● Accountable for training new CST members
● May also, as appropriate, support relevant sub-teams in assigning and training new team members
● Participates in ongoing enhancements/development of core and sub-team processes, structures, systems, tools and other resources
● Where assigned/appointed, expected to represent CD on core teams, e.g., Lifecycle Team (LCT). Ability to act as the Global Development Leader (GDL) as needed and may be considered for permanent GDL positions when appropriate
Regulatory Activities
● Leads development of briefing packages by providing clinical science information and input
● Leads development of responses to HA questions by providing clinical science information and input
● Leads health authority (HA) interactions
● Takes a lead role with other CST members, regulatory and other internal
partners/stakeholders in the completion and submission of regulatory filings and other regulatory documentation. Provides clinical science information and input for regulatory submissions and other regulatory processes. Includes developing label and packaging language, etc.
Local/Global Communities
● Serves a significant role in the local site community, promotes discussion in the community, Clinical science representative on site-wide initiatives. Visible in the global PDC community, e.g. contributing to All Staff meetings/offsites
Disease/Therapeutic Area
● Contributes clinical science input into the relevant therapeutic/disease area scientific strategy. Helps research and other PD groups to ensure consistency of scientific and late-development strategies with target label claims and corporate goals. As appropriate/needed, performs clinical assessments on relevant drug discovery projects

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Roche is an Equal Opportunity Employer.